Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
Chongqing Peg-Bio Biopharm Co., Ltd.
We are professional supplier of Intermediate of Semaglutide(P29).
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
1 Product Details
Chinese name:Recombinant Lysyl Endopeptidase English name:Recombinant Lysyl Endopeptidase (rLys-C)
CAS:72561-05-8 Brand:IMED
Place of Origin:Chongqing Storage Condition:-15℃
Purity:>96% Product Category:Recombinant Protease
Grade:Pharmaceutical grade Alias:Recombinant lysyl endonuclease
Specification:1mg/branch,10mg/branch,0.5g/bottle
Main Uses:In the field of biomedical industry, rLys-C is used in the production and preparation of peptides and insulin analogs, such as Mentholatum, Ditropan, Degulin, etc.; in the field of scientific research, it is used in the study of proteomics, sequencing of peptides, identification of phosphorylated peptides, analysis of disulfide bonds, analysis of N-glycans and so on.
2 Product Description
Lysyl Endopeptidase (LysylEndopeptidase or Achromobacterprotease I, EC 3.4.21.50) is a serine
protease that specifically recognizes and cleaves the peptide bond at the carboxyl end of Lys
in peptide chains. Recombinant lysyl endopeptidase (rLys-C) produced by Chongqing IMED
is selected from Achromobacterlyticus. source and prepared by using E. coli recombinant table,
and its enzyme activity properties are consistent with natural Lys-C.
The product FDA DMF has been filed: 039016.
3 Quality standard
Appearance | White or off-white lyophilized powder |
Purity (RP-HPLC) | Not less than 90% |
Relative molecular weight | 31kDa±3.1kDa |
Enzyme specific activity | Not less than 3.0AU/mg |
Protein content | Not less than 20% |
Bacterial protein residue | Not more than 0.05% |
Exogenous DNA residue | Not higher than 10ng/mg |
Bacterial endotoxin | Not higher than 500EU/mg |
Microbial limit | No more than 100cfu/g of total number of colonies |
4 Product Advantages
Compared with Lys-C from Pseudomonas aeruginosa and other sources, this product has
a higher enzymatic efficiency at PK and DK sites;
Recombinant expression preparation, without the risk of residual heterozymes such as
Lys-N and Arg-C;
No animal source materials are used in the production process, no risk of exogenous
virus contamination;
3000L fermentation scale production line, annual output of not less than 8kg; verified by
multiple batch production, highly consistent quality between batches;
The production workshop is operated according to GMP, and the production equipment,
environment and process control are implemented with reference to the Good Manufacturing Practice (GMP);
Complementary rLys-C protease trace residue detection kit is available;
DMF has been filed: 039016, and relevant regulatory support documents can be provided
according to customer requirements;
Customized packaging specifications are available according to customer requirements.
5 Packaging and transportation
This product is in the form of lyophilized powder, packaged in HDPE bottles for oral medication, which is convenient for transportation and storage; it can be stored for at least 2 years under -15℃. The whole process of cold chain transportation, the whole temperature monitoring from leaving the warehouse to receiving the goods.